For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
A transdermal drug patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Transdermal patches are presently being marketed which can be worn anywhere from as little as eight hours to as long as seven days, depending on their therapeutic indication.
Scope of the Report:
Transdermal drug patches production has relatively high technology barrier and is technology intensive industry. Currently, there are many producing companies in the USA transdermal drug patches industry. The main market players are Noven, Mylan, Novartis and Johnson & Johnson. The production of transdermal drug patches will increase to 477482 K Units in 2016 from 340530 K Units in 2011 with average growth rate of 7.00%. USA transdermal drug patches capacity utilization rate remained at around 76.86% in 2015.
Transdermal drug patches mainly has some types, which include fentanyl transdermal patch, nicotine transdermal patch, buprenorphine transdermal patch, clonidine transdermal patch and oxybutynin transdermal patch. With medical effect of transdermal drug patches, the downstream application industries will need more transdermal drug patches products.
The major raw materials for transdermal drug patches are scopolamine, clonidine, nitroglycerin, isosorbide dinitrate, estradiol, norethindrone acetate and fentanyl, etc. Fluctuations in the price of the upstream product will impact on the production cost of transdermal drug patches, and then impact the price of transdermal drug patches. The production cost of transdermal drug patches is also an important factor which could impact the price of transdermal drug patches. The transdermal drug patches manufacturers are trying to produce many more types of transdermal drug patches for other different diseases.
The worldwide market for Transdermal Drug Patches is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Transdermal Drug Patches in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
- Johnson & Johnson
- Agile Therapeutics
- Teikoku Pharma USA
- Immune Pharmaceuticals
- Hercon Pharmaceuticals
- DURECT Corporation
- Xel Pharmaceuticals
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- Fentanyl Transdermal Patch
- Nicotine Transdermal Patch
- Buprenorphine Transdermal Patch
- Clonidine Transdermal Patch
- Oxybutynin Transdermal Patch
Market Segment by Applications, can be divided into
- Used for Hypertension
- Used for Contraception
- Used for Analgesia
- Used for Smoking Cessation
- Used for Angina
- Used for Hormone Replacement
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Transdermal Drug Patches product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Transdermal Drug Patches, with price, sales, revenue and global market share of Transdermal Drug Patches in 2017 and 2018.
Chapter 3, the Transdermal Drug Patches competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Transdermal Drug Patches breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Transdermal Drug Patches market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Transdermal Drug Patches sales channel, distributors, customers, research findings and conclusion, appendix and data source.